US
US Left Atrial Appendage Closure Market Industry Trends and Forecast to 2034: Segmented by (Product, Setting, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
US · 2024–2034 · estimates
Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
US (this report) at $963.1 Mn.
Canada at 15.6% a year.Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$2.24 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $842.6 Mn | — | — |
| 2025 (base) | $963.1 Mn | +$120.5 Mn | — |
| 2026 (forecast) | $1.10 Bn | +$137.7 Mn | +14.3% |
| 2027 (forecast) | $1.26 Bn | +$157.4 Mn | +30.6% |
| 2028 (forecast) | $1.44 Bn | +$179.9 Mn | +49.3% |
| 2029 (forecast) | $1.64 Bn | +$205.7 Mn | +70.7% |
| 2030 (forecast) | $1.88 Bn | +$235.1 Mn | +95.1% |
| 2031 (forecast) | $2.15 Bn | +$268.7 Mn | +123% |
| 2032 (forecast) | $2.45 Bn | +$307.1 Mn | +154.9% |
| 2033 (forecast) | $2.81 Bn | +$351.0 Mn | +191.3% |
| 2034 (forecast) | $3.21 Bn | +$401.2 Mn | +233% |
Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
US (this report)
$963.1 Mn
Canada
$185.9 Mn
China
$158.8 Mn
Japan
$132.5 Mn
Germany
$72.1 Mn
UK
$61.4 Mn
Brazil
$56.0 Mn
Italy
$52.9 Mn
France
$50.3 Mn
India
$46.4 Mn
Saudi Arabia
$40.2 Mn
Spain
$37.7 Mn
Ecuador
$37.2 Mn
Mexico
$33.9 Mn
New Zealand
$24.1 Mn
Australia
$24.8 Mn
Russia
$18.5 Mn
South Africa
$15.9 Mn
UAE
$9.7 Mn
Egypt
$6.7 Mn
Philippines
$4.9 Mn
Hong Kong
$3.8 Mn
Malaysia
$3.6 Mn
Singapore
$3.0 Mn
Thailand
$2.6 Mn
Kenya
$1.6 Mn
Left atrial appendage closure devices seal off a small pouch in the heart to lower stroke risk in people with atrial fibrillation.
Key segments of the left Atrial Appendage Closure market include product (Endocardial Devices and Epicardial Devices) and setting (Hospitals and Cardiac Centers).
Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the left Atrial Appendage Closure market.
Less invasive procedures, remote monitoring of implanted devices and rising access to cardiac care in emerging markets give the left Atrial Appendage Closure market room to grow.
High device prices, the need for trained specialists, reimbursement pressure and product recalls hold back the left Atrial Appendage Closure market.
The left Atrial Appendage Closure market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how left Atrial Appendage Closure products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in US.
What doctors and scientists are doing in Left Atrial Appendage Closure right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 13 Nov 2026.
[4] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
From our blog
US · 1 shared keyword
US · 1 shared keyword
US · 1 shared keyword
US · 1 shared keyword
US · 1 shared keyword
US · 1 shared keyword
Digital Health · US
Digital Health · US
Pharmaceuticals · US
Pharmaceuticals · US
Pharmaceuticals · US
Pharmaceuticals · US